Dennis M. Lanfear - Jan 20, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
President & CEO, Director
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Dennis M. Lanfear
Stock symbol
CHRS
Transactions as of
Jan 20, 2023
Transactions value $
$0
Form type
4
Date filed
1/24/2023, 03:50 PM
Previous filing
Jan 6, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Award $0 +86.3K +15.17% $0.00 655K Jan 20, 2023 Direct F1
holding CHRS Common Stock 433K Jan 20, 2023 By Trust F2
holding CHRS Common Stock 87K Jan 20, 2023 By LLC F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
F2 These shares are held by the Lanfear Revocable Trust, dated January 27, 2004, as restated, of which Reporting Person is a trustee.
F3 These shares are held by Lanfear Capital Advisors, LLC of which Reporting Person is President.